REQUEST A DEMO
Total
USD $0.00
Search more companies

Nucleome Informatics Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nucleome Informatics Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Nucleome Informatics Private Limited is an unlisted company, incorporated on 23/11/2012. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2012PTC072774 and registration number is 072774. The company is a professional, scientific and technical company, it is engaged in other professional, scientific and technical activities.

Legal Address
G-901, Safal Parisar, South Bopal Sp Ring Road, Bopal
Ahmedabad; Gujarat; Postal Code: 380058

Contact Details: Purchase the Nucleome Informatics Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Nucleome Informatics Private Limited report to view the information.
Outstanding Shares:
Purchase the Nucleome Informatics Private Limited report to view the information.
Registered Capital:
Purchase the Nucleome Informatics Private Limited report to view the information.
Incorporation Date:
November 23, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Nucleome Informatics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
10.14%
Total operating revenue
26.52%
Operating profit (EBIT)
-37.99%
EBITDA
-21.53%
Net Profit (Loss) for the Period
2.01%
Total assets
2.41%
Total equity
5.14%
Operating Profit Margin (ROS)
-1.69%
Net Profit Margin
-0.17%
Return on Equity (ROE)
-0.15%
Debt to Equity Ratio
-15.61%
Quick Ratio
-0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?